These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30737674)

  • 1. Insights for Care: The Healthcare Utilisation and Cost Impact of Managing Type 2 Diabetes-Associated Microvascular Complications.
    Chapman D; Foxcroft R; Dale-Harris L; Ronte H; Bidgoli F; Bellary S
    Diabetes Ther; 2019 Apr; 10(2):575-585. PubMed ID: 30737674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden and pattern of micro vascular complications in type 2 diabetes in a tertiary health institution in Nigeria.
    Olamoyegun M; Ibraheem W; Iwuala S; Audu M; Kolawole B
    Afr Health Sci; 2015 Dec; 15(4):1136-41. PubMed ID: 26958014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Changes in Medical Services and Related Costs in a Single Cohort of Patients Newly Diagnosed With Type 2 Diabetes, 2006 to 2012.
    Weng W; Liang Y; Kimball ES; Hobbs T; Kong S; Sakurada B; Bouchard J
    Clin Ther; 2016 Jun; 38(6):1314-1326. PubMed ID: 27129399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
    Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
    Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care: A Matched Cohort Study.
    O'Brien R; Johnson E; Haneuse S; Coleman KJ; O'Connor PJ; Fisher DP; Sidney S; Bogart A; Theis MK; Anau J; Schroeder EB; Arterburn D
    Ann Intern Med; 2018 Sep; 169(5):300-310. PubMed ID: 30083761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of and factors related to microvascular complications in patients with type 2 diabetes mellitus in Tianjin, China: a cross-sectional study.
    Bui HDT; Jing X; Lu R; Chen J; Ngo V; Cui Z; Liu Y; Li C; Ma J
    Ann Transl Med; 2019 Jul; 7(14):325. PubMed ID: 31475195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvascular Complications of Type 2 Diabetes Mellitus.
    Faselis C; Katsimardou A; Imprialos K; Deligkaris P; Kallistratos M; Dimitriadis K
    Curr Vasc Pharmacol; 2020; 18(2):117-124. PubMed ID: 31057114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sarpogrelate on microvascular complications with type 2 diabetes.
    Yoo H; Park I; Kim DJ; Lee S
    Int J Clin Pharm; 2019 Apr; 41(2):563-573. PubMed ID: 30864083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity network for chronic disease: A novel approach to understand type 2 diabetes progression.
    Khan A; Uddin S; Srinivasan U
    Int J Med Inform; 2018 Jul; 115():1-9. PubMed ID: 29779710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic microvascular complications: can patients at risk be identified? A review.
    Girach A; Manner D; Porta M
    Int J Clin Pract; 2006 Nov; 60(11):1471-83. PubMed ID: 17073842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Medical Costs of Incident Complications in Patients Newly Diagnosed With Type 2 Diabetes in China.
    He X; Zhang Y; Zhou Y; Dong C; Wu J
    Diabetes Ther; 2021 Jan; 12(1):275-288. PubMed ID: 33206365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominant Complications of Type 2 Diabetes in Kumasi: A 4-Year Retrospective Cross-Sectional Study at a Teaching Hospital in Ghana.
    Annani-Akollor ME; Addai-Mensah O; Fondjo LA; Sallah L; Owiredu EW; Acheampong E; Akamugri S
    Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31075814
    [No Abstract]   [Full Text] [Related]  

  • 14. Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.
    Gandra SR; Lawrence LW; Parasuraman BM; Darin RM; Sherman JJ; Wall JL
    J Manag Care Pharm; 2006 Sep; 12(7):546-54. PubMed ID: 16981800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications.
    Zhuo X; Zhang P; Hoerger TJ
    Am J Prev Med; 2013 Sep; 45(3):253-61. PubMed ID: 23953350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of microvascular complications of type 2 diabetes: A 12 year longitudinal study from Karachi-Pakistan.
    Fawwad A; Mustafa N; Zafar AB; Khalid M
    Pak J Med Sci; 2018; 34(5):1058-1063. PubMed ID: 30344550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of the economic and health impact of complications of type 2 diabetes mellitus in the autonomous community of Madrid (Spain).
    Arrieta F; Rubio-Terrés C; Rubio-Rodríguez D; Magaña A; Piñera M; Iglesias P; Nogales P; Calañas A; Novella B; Botella-Carretero JI; Debán C; Zamarrón I; Mora G; Balsa JA; Vázquez C;
    Endocrinol Nutr; 2014 Apr; 61(4):193-201. PubMed ID: 24440211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal study of healthcare utilisation and expenditure in people with type 2 diabetes mellitus with and without major depressive disorder.
    Huang CJ; Lin CH; Hsieh HM; Chang CC; Chu CC; Sun DP; Weng SF
    Gen Hosp Psychiatry; 2019; 57():50-58. PubMed ID: 30908962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost of treating type 2 diabetes (CODEIRE).
    Nolan JJ; O'Halloran D; McKenna TJ; Firth R; Redmond S
    Ir Med J; 2006; 99(10):307-10. PubMed ID: 17274175
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.